Year archive

PharmaCorp Rx — 2025 filings

All 34 regulatory filings released by PharmaCorp Rx (PCRX) in 2025, sourced directly from the official regulator.

34 Filings

2025 Period

2025 filings (34)

Filing	Released	Lang
Material change report - English.pdf Board/Management Information	2025-12-04	English
News release - English.pdf Earnings Release Q3 2025	2025-11-29	English
News release - English.pdf Board/Management Information	2025-11-29	English
Prospectus (non pricing) supplement (other than ATM) – English.pdf Capital/Financing Update	2025-11-08	English
Underwriting or agency agreements (or amendment thereto).pdf Capital/Financing Update	2025-11-08	English
Consent letter of issuer's legal counsel.pdf Capital/Financing Update	2025-11-08	English
Consent letter of underwriters' legal counsel.pdf Capital/Financing Update	2025-11-08	English
Auditors' consent letter.pdf Regulatory Filings	2025-11-08	English
Marketing materials (other than specified derivative) - English.pdf Capital/Financing Update	2025-11-05	English
News release - English.pdf Capital/Financing Update	2025-11-05	English
Decision Document (Preliminary).pdf Share Issue/Capital Change	2025-09-26	English
Preliminary short form prospectus – English.pdf Capital/Financing Update	2025-09-26	English
Qualification certificate.pdf Regulatory Filings	2025-09-26	English
Other.pdf Investor Presentation	2025-09-08	English
News release - English.pdf M&A Activity	2025-09-08	English
NI 44-101 Notice of intent to qualify – English.pdf Capital/Financing Update	2025-08-01	English
Annual information form - English.pdf Regulatory Filings FY 2024	2025-07-31	English
News release - English.pdf Report Publication Announcement	2025-07-31	English
52-109F1-AIF - Certification of filings with voluntarily filed AIF - CFO(E).pdf Regulatory Filings	2025-07-31	English
52-109F1-AIF - Certification of filings with voluntarily filed AIF - CEO(E).pdf Regulatory Filings	2025-07-31	English
Annual information form - English.pdf Report Publication Announcement	2025-07-31	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-05-28	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-05-28	English
Interim MD&A - English.pdf Management Reports	2025-05-28	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2025-05-28	English
News release - English.pdf M&A Activity	2025-05-01	English
News release - English.pdf Report Publication Announcement	2025-04-22	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-04-22	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-04-22	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-04-22	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-04-22	English
Annual MD&A - English.pdf Management Reports	2025-04-22	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2024	2025-04-22	English
News release - English.pdf M&A Activity	2025-04-03	English